Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis

Clinical trial NCT02586402 · UNKNOWN

Trial details

NCT number: NCT02586402
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Renal Failure Anemia Dialysis

Start date: 2015-10-01
Primary completion: 2016-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.